Seres Therapeutics, Inc. (MCRB) quarterly income statement — complete revenue, gross profit & net income history
Seres Therapeutics, Inc. (MCRB) annual income statement — 14-year revenue, gross profit & net income history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Sales/Revenue | 593K | 736K | 358K | 438K | 351K | 0 | 0 | 0 | 0 | 0 | 0 | 64K | 0 | 126.47M | -522K | 975K | 3.44M | 1.22M | 1.49M | 7.22M |
| Revenue Growth % | 68.95% | - | - | - | - | - | - | -100% | - | -100% | 100% | -93.44% | -100% | 10300.74% | -134.96% | -86.5% | -97.28% | -76.9% | -73.89% | -58.89% |
| Cost of Goods Sold | 481K | 0 | 0 | 592K | 736K | 1.69M | 3.53M | 3.53M | 0 | 0 | 19.49M | 0 | 0 | 46.79M | 43.97M | 46.22M | 0 | 43.94M | 39.65M | 36.75M |
| COGS % of Revenue | 81.11% | - | - | 135.16% | 209.69% | - | - | - | - | - | - | - | - | 37% | -8423.18% | 4740.51% | - | 3613.08% | 2655.66% | 508.96% |
| Gross Profit | 112K | 736K | 358K | -154K | -385K | -1.69M | -3.53M | -3.53M | 0 | 0 | -19.49M | 64K | 0 | 79.68M | -44.49M | -45.24M | 3.44M | -42.72M | -38.16M | -29.53M |
| Gross Margin % | 18.89% | 100% | 100% | -35.16% | -109.69% | - | - | - | - | - | - | 100% | - | 63% | 8523.18% | -4640.51% | 100% | -3513.08% | -2555.66% | -408.96% |
| Gross Profit Growth % | 129.09% | 143.58% | 110.15% | 95.64% | - | - | 81.91% | -5618.75% | - | -100% | 56.18% | 100.14% | -100% | 286.52% | -16.6% | -53.21% | -96.03% | -39.19% | -61.78% | -304.37% |
| Operating Expenses | 10.56M | 22.01M | 21.27M | 19.22M | 22.09M | 23.19M | 23.71M | 25.3M | 29.17M | 28.87M | 14.94M | 39.59M | 44.59M | 30.16M | 26.08M | 23.06M | 62.55M | 20.61M | 17.59M | 19.9M |
| OpEx % of Revenue | 1780.61% | 2990.35% | 5939.94% | 4388.81% | 6294.02% | - | - | - | - | - | - | 61859.38% | - | 23.84% | -4995.59% | 2365.33% | 1816.23% | 1694.57% | 1178.5% | 275.6% |
| Selling, General & Admin | 5.45M | 7.06M | 8.07M | 7.54M | 9.48M | 10.25M | 11.89M | 12.46M | 12.71M | 13.06M | 14.94M | 17.23M | 19.43M | 28.05M | 22.47M | 22.4M | 18.38M | 20.34M | 18.57M | 20.51M |
| SG&A % of Revenue | 918.72% | 959.38% | 2254.19% | 1721.23% | 2699.72% | - | - | - | - | - | - | 26928.13% | - | 22.18% | -4304.6% | 2297.85% | 533.8% | 1672.29% | 1243.87% | 283.98% |
| Research & Development | 5.59M | 9.14M | 13.2M | 11.68M | 12.62M | 12.94M | 11.82M | 12.84M | 16.46M | 15.81M | 19.49M | 26.85M | 25.15M | 46.79M | 43.97M | 46.22M | 43.12M | 43.94M | 39.65M | 36.75M |
| R&D % of Revenue | 943% | 1241.98% | 3685.75% | 2667.58% | 3594.3% | - | - | - | - | - | - | 41946.88% | - | 37% | -8423.18% | 4740.51% | 1251.92% | 3613.08% | 2655.66% | 508.96% |
| Other Operating Expenses | -481K | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1000K | -1000K | 0 | -1000K | -1000K | -1000K | 1000K | -1000K | -1000K | -1000K |
| Operating Income | -10.45M | -21.27M | -20.91M | -19.38M | -22.48M | -24.88M | -27.24M | -28.84M | -29.17M | -28.87M | -34.44M | -39.53M | -44.59M | 49.52M | -70.57M | -68.31M | -59.11M | -63.33M | -55.75M | -49.43M |
| Operating Margin % | -1761.72% | -2890.35% | -5839.94% | -4423.97% | -6403.7% | - | - | - | - | - | - | -61759.38% | - | 39.16% | 13518.77% | -7005.85% | -1716.23% | -5207.65% | -3734.16% | -684.56% |
| Operating Income Growth % | 53.52% | 14.5% | 23.24% | 32.8% | 22.94% | 13.82% | 20.91% | 27.05% | 34.58% | -158.3% | 51.2% | 42.13% | 24.57% | 178.21% | -26.58% | -38.18% | -186.4% | -31.54% | -57.82% | -176.19% |
| EBITDA | -9.97M | -20.6M | -20.13M | -18.42M | -21.43M | -23.82M | -26.16M | -27.75M | -27.77M | -27.45M | -32.88M | -37.89M | -42.9M | 51.05M | -69.17M | -66.68M | -57.36M | -61.64M | -54.18M | -47.88M |
| EBITDA Margin % | -1680.61% | -2799.32% | -5621.79% | -4206.16% | -6106.27% | - | - | - | - | - | - | -59209.38% | - | 40.37% | 13250.57% | -6838.97% | -1665.51% | -5069.08% | -3629% | -663.07% |
| EBITDA Growth % | 53.5% | 13.51% | 23.07% | 33.61% | 22.81% | 13.22% | 20.44% | 26.77% | 35.28% | -153.77% | 52.46% | 43.17% | 25.21% | 182.82% | -27.66% | -39.26% | -182.06% | -31.95% | -60.06% | -192.15% |
| D&A (Non-Cash Add-back) | 481K | 670K | 781K | 954K | 1.04M | 1.06M | 1.08M | 1.08M | 1.4M | 1.42M | 1.56M | 1.63M | 1.68M | 1.53M | 1.4M | 1.63M | 1.75M | 1.69M | 1.57M | 1.55M |
| EBIT | -10.45M | -21.27M | -19.91M | -15.34M | 8.2M | -19.86M | 32.68M | -15.64M | -51.03M | -26.2M | -32.28M | -37.22M | -41.02M | 49.52M | -70.57M | -68.31M | -58.27M | -63.33M | -55.75M | -49.43M |
| Net Interest Income | 146K | 181K | 325K | 445K | 618K | 546K | 618K | 437K | 652K | -2.22M | -3.02M | -2.06M | -1.44M | -1.46M | -916K | -466K | -862K | -1.11M | -528K | -253K |
| Interest Income | 146K | 181K | 325K | 445K | 618K | 546K | 618K | 437K | 652K | 1.23M | 1.65M | 1.97M | 2.57M | 1.73M | 1.03M | 1.41M | 865K | 395K | 384K | 485K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.45M | 4.66M | 4.03M | 4.01M | 3.19M | 1.95M | 1.88M | 1.73M | 1.5M | 912K | 738K |
| Other Income/Expense | -5.84M | 25.85M | 994K | 4.04M | 30.68M | 5.03M | 59.92M | 13.2M | -21.86M | 2.67M | 1.53M | -1.72M | 3.57M | -2.97M | -606K | -489K | -895K | -1.41M | -873K | -569K |
| Pretax Income | -16.29M | 4.58M | -19.91M | -15.34M | 8.2M | -19.86M | 32.68M | -15.64M | -51.03M | -26.2M | -32.9M | -41.25M | -41.02M | 46.55M | -71.17M | -68.8M | -60M | -64.73M | -56.62M | -50M |
| Pretax Margin % | -2746.37% | 622.42% | -5562.29% | -3501.14% | 2337.32% | - | - | - | - | - | - | -64450% | - | 36.81% | 13634.87% | -7056% | -1742.22% | -5323.6% | -3792.63% | -692.44% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -16.29M | 4.58M | -19.91M | -15.34M | 8.2M | -19.86M | 32.68M | -15.64M | 88.78M | -32.87M | -40.13M | -41.25M | -47.85M | 46.55M | -71.17M | -68.8M | -60M | -64.73M | -56.62M | -50M |
| Net Margin % | -2746.37% | 622.42% | -5562.29% | -3501.14% | 2337.32% | - | - | - | - | - | - | -64450% | - | 36.81% | 13634.87% | -7056% | -1742.22% | -5323.6% | -3792.63% | -692.44% |
| Net Income Growth % | -298.51% | 123.07% | -160.93% | 1.93% | -90.76% | 39.6% | 181.43% | 62.09% | 285.51% | -170.61% | 43.61% | 40.04% | 20.25% | 171.91% | -25.7% | -37.59% | -187.96% | -33.94% | -59.66% | -173.95% |
| Net Income (Continuing) | -16.29M | 4.58M | -19.91M | -15.34M | 8.2M | -19.86M | 32.68M | -15.64M | -51.03M | -26.2M | -32.9M | -41.25M | -41.02M | 46.55M | -71.17M | -68.8M | -60M | -64.73M | -56.62M | -50M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K | -1000K | -1000K | 0 | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.63 | 0.49 | -2.08 | -1.73 | 0.94 | -2.27 | 3.75 | -1.81 | 0.58 | -4.34 | -5.49 | -6.38 | -7.46 | 7.17 | -11.31 | -10.99 | -9.79 | -14.03 | -12.29 | -10.88 |
| EPS Growth % | -273.4% | 121.59% | -155.47% | 4.42% | 62.07% | 47.7% | 168.31% | 71.64% | 107.77% | -160.53% | 51.46% | 41.92% | 23.83% | 151.09% | 7.96% | -0.96% | -168.16% | -33.08% | -58.56% | -172.67% |
| EPS (Basic) | -1.63 | 0.49 | -2.08 | -1.73 | 0.94 | -2.27 | 3.76 | -1.81 | 0.58 | -4.34 | -5.49 | -6.38 | -7.46 | 7.29 | -11.31 | -10.99 | -9.79 | -14.03 | -12.29 | -10.88 |
| Diluted Shares Outstanding | 9.98M | 9.64M | 9.58M | 8.87M | 8.77M | 8.74M | 8.71M | 155.4M | 152.65M | 7.58M | 7.31M | 6.46M | 6.41M | 6.49M | 6.29M | 6.26M | 6.13M | 4.61M | 4.61M | 4.59M |
| Basic Shares Outstanding | 9.98M | 9.64M | 9.58M | 8.86M | 8.76M | 8.74M | 8.7M | 155.4M | 152.65M | 7.58M | 7.31M | 6.46M | 6.41M | 6.39M | 6.29M | 6.26M | 6.13M | 4.61M | 4.61M | 4.59M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |